Although, there are various therapeutic methods for OA, such as surgery, drug and adjuvant therapy, it is difficult to completely stop the development of OA, which results in continuous pain and even long-term disability [6]
Research has shown that it can simultaneously support fat loss while protecting lean mass, often considered a "holy grail" for dieters
Controlled release nutraceutical APIs in liposomal technology facilitate delivery at a specified time, which further maximizes long-term benefits in nutraceuticals [17]
Post-thyroidectomy metabolism is already altered
In most cases, GLP-1 weight loss drugs are meant to be used alongside lifestyle changes, not in place of them
Inhibition of Gln, when combined with radiotherapy, triggers ferroptosis in immunogenic tumors